why choose us

First received: August 20, 2022

Clinical Trial: LIthium as Bridging thErapy Prior to Radioactiveiodine in hyperThYroidism

Study Status: Completed

Recruit Status: Completed

Condition: Hyperthyroidism/Thyrotoxicosis

Study Type: Interventional


Official Title: A Randomized Controlled Clinical Trial on the Effectiveness of Lithium in Comparison to Carbimazole as a Bridging Therapy Prior to Radioactive Iodine for Hyperthyroidism

Brief Summary: A prospective randomised controlled open label, single centre study. subjects will be randomised into lithium or carbimazole arms in a 1:1 ratio. Lithium arm will receive tab Lithium Carbonate 300mg daily while Carbimazole arm will receive tab Carbimazole 10mg daily for a duration of two months prior to radioactive iodine treatment. Changes in the thyroid hormone levels at 2 months of treatment and at months 1,3 and 6 following radioactive iodine will be evaluated.

Read more